Additionally, we used computational modeling to investigate the individual contribution of changes in prothrombin conversion and thrombin inactivation to the differences in TG, and to study the consequences of these changes in pro- and anticoagulant processes for the bleeding management in cirrhosis patients. Here, F2 is linked to Cirrhosis.